Credit Agricole S A Esperion Therapeutics, Inc. Transaction History

Credit Agricole S A

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $82,782 - $156,001	-7,300 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$19.4 - $28.71 $46,560 - $68,904	2,400 Added 48.98%	7,300 $154,000
Q1 2021 May 17, 2021	BUY	$25.12 - $36.89 $123,088 - $180,761	4,900 New	4,900 $137,000
Q4 2017 Feb 13, 2018	SELL	$43.47 - $67.43 $6.86 Million - $10.6 Million	-157,900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $6.92 Million - $8.33 Million	157,900	157,900 $7.91 Million

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.